JP2008543314A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008543314A5 JP2008543314A5 JP2008517145A JP2008517145A JP2008543314A5 JP 2008543314 A5 JP2008543314 A5 JP 2008543314A5 JP 2008517145 A JP2008517145 A JP 2008517145A JP 2008517145 A JP2008517145 A JP 2008517145A JP 2008543314 A5 JP2008543314 A5 JP 2008543314A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- nva
- nle
- peptide
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000765 processed proteins & peptides Proteins 0.000 claims 43
- 102000008949 Histocompatibility Antigens Class I Human genes 0.000 claims 16
- 108010088652 Histocompatibility Antigens Class I Proteins 0.000 claims 16
- 150000001413 amino acids Chemical class 0.000 claims 8
- 230000002163 immunogen Effects 0.000 claims 8
- 102000004196 processed proteins & peptides Human genes 0.000 claims 8
- 229920001184 polypeptide Polymers 0.000 claims 7
- 238000000034 method Methods 0.000 claims 6
- 102000039446 nucleic acids Human genes 0.000 claims 5
- 108020004707 nucleic acids Proteins 0.000 claims 5
- 150000007523 nucleic acids Chemical class 0.000 claims 5
- 230000001939 inductive effect Effects 0.000 claims 4
- 238000006467 substitution reaction Methods 0.000 claims 3
- 102000025850 HLA-A2 Antigen Human genes 0.000 claims 2
- 108010074032 HLA-A2 Antigen Proteins 0.000 claims 2
- 102000036673 PRAME Human genes 0.000 claims 2
- 108060006580 PRAME Proteins 0.000 claims 2
- 230000005867 T cell response Effects 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 2
- 238000010494 dissociation reaction Methods 0.000 claims 2
- 230000005593 dissociations Effects 0.000 claims 2
- 230000003308 immunostimulating effect Effects 0.000 claims 2
- 210000001744 T-lymphocyte Anatomy 0.000 claims 1
- 239000013612 plasmid Substances 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US69188905P | 2005-06-17 | 2005-06-17 | |
| PCT/US2006/023489 WO2006138562A2 (en) | 2005-06-17 | 2006-06-16 | Epitope analogues |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008543314A JP2008543314A (ja) | 2008-12-04 |
| JP2008543314A5 true JP2008543314A5 (enExample) | 2009-08-06 |
Family
ID=37571207
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008517145A Pending JP2008543314A (ja) | 2005-06-17 | 2006-06-16 | エピトープ類似体 |
Country Status (12)
| Country | Link |
|---|---|
| US (5) | US7511119B2 (enExample) |
| EP (4) | EP2371852A3 (enExample) |
| JP (1) | JP2008543314A (enExample) |
| KR (1) | KR20080028938A (enExample) |
| CN (1) | CN101273056A (enExample) |
| AU (1) | AU2006259307B2 (enExample) |
| BR (1) | BRPI0611793A2 (enExample) |
| CA (1) | CA2612494A1 (enExample) |
| IL (2) | IL188108A (enExample) |
| MX (1) | MX2007015951A (enExample) |
| NZ (2) | NZ564359A (enExample) |
| WO (1) | WO2006138562A2 (enExample) |
Families Citing this family (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6977074B2 (en) | 1997-07-10 | 2005-12-20 | Mannkind Corporation | Method of inducing a CTL response |
| US7178491B2 (en) * | 2003-06-05 | 2007-02-20 | Caterpillar Inc | Control system and method for engine valve actuator |
| AU2005321898B2 (en) * | 2004-12-29 | 2012-07-19 | Mannkind Corporation | Use of compositions comprising various tumor-associated antigens as anti-cancer vaccines |
| EP1838342A2 (en) * | 2004-12-29 | 2007-10-03 | Mannkind Corporation | Methods to bypass cd+4 cells in the induction of an immune response |
| EP2351576A1 (en) * | 2004-12-29 | 2011-08-03 | Mannkind Corporation | Methods to trigger, maintain and manipulate immune responses by targeted administration of biological response modifiers into lymphoid organs |
| KR20080033271A (ko) * | 2005-06-17 | 2008-04-16 | 맨카인드 코포레이션 | 암종을 위한 다가 동반이행 및 증폭형 면역치료제 |
| CA2612516C (en) | 2005-06-17 | 2015-03-24 | Mannkind Corporation | Methods and compositions to elicit multivalent immune responses against dominant and subdominant epitopes, expressed on cancer cells and tumor stroma |
| US7511119B2 (en) * | 2005-06-17 | 2009-03-31 | Mannkind Corporation | PRAME peptide analogues |
| US20080014211A1 (en) * | 2006-07-14 | 2008-01-17 | Mannkind Corporation | Methods to elicit, enhance and sustain immune responses against MHC class I-restricted epitopes, for prophylactic and therapeutic purposes |
| CN106220721B (zh) * | 2007-03-26 | 2020-04-07 | 莱顿大学医学中心附属莱顿教学医院 | Prame衍生的肽以及包括该肽的免疫原组合物 |
| JP2010528591A (ja) * | 2007-05-23 | 2010-08-26 | マンカインド コーポレイション | マルチシストロン性ベクター及びそれらの設計方法 |
| PL219335B1 (pl) * | 2008-07-04 | 2015-04-30 | Inst Biotechnologii I Antybiotyków | Pochodna insuliny lub jej farmaceutycznie dopuszczalna sól, jej zastosowanie oraz zawierająca ją kompozycja farmaceutyczna |
| WO2011050344A2 (en) | 2009-10-23 | 2011-04-28 | Mannkind Corporation | Cancer immunotherapy and method of treatment |
| EP3018146A1 (en) * | 2009-11-18 | 2016-05-11 | MannKind Corporation | Monoclonal antibodies and diagnostic uses thereof |
| US9109007B2 (en) | 2010-08-18 | 2015-08-18 | Purdue Pharma L.P. | MHC-I restricted epitopes containing non-natural amino acid residues |
| CN103124740B (zh) * | 2010-09-21 | 2015-09-02 | 美国卫生和人力服务部 | 抗-ssx-2t细胞受体和相关材料及使用方法 |
| JP2014527801A (ja) * | 2011-09-01 | 2014-10-23 | ユニバーシティ オブ サザン カリフォルニア | ハイスループットペプチドミメティックを調製するための方法、経口バイオアベイラブルな薬物およびそれを含有する組成物 |
| WO2014200910A2 (en) * | 2013-06-10 | 2014-12-18 | Iogenetics, Llc | Bioinformatic processes for determination of peptide binding |
| US9340799B2 (en) | 2013-09-06 | 2016-05-17 | President And Fellows Of Harvard College | MRNA-sensing switchable gRNAs |
| AU2015298571B2 (en) | 2014-07-30 | 2020-09-03 | President And Fellows Of Harvard College | Cas9 proteins including ligand-dependent inteins |
| CN107266552B (zh) * | 2016-03-30 | 2022-02-08 | 香雪生命科学技术（广东）有限公司 | 源自于prame的肿瘤抗原短肽 |
| EP3592381A1 (en) | 2017-03-09 | 2020-01-15 | President and Fellows of Harvard College | Cancer vaccine |
| KR20190127797A (ko) | 2017-03-10 | 2019-11-13 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | 시토신에서 구아닌으로의 염기 편집제 |
| CN111801345A (zh) | 2017-07-28 | 2020-10-20 | 哈佛大学的校长及成员们 | 使用噬菌体辅助连续进化(pace)的进化碱基编辑器的方法和组合物 |
| EP3724214A4 (en) | 2017-12-15 | 2021-09-01 | The Broad Institute Inc. | SYSTEMS AND METHODS FOR PREDICTING REPAIR RESULTS IN GENETIC ENGINEERING |
| US11814420B2 (en) | 2018-07-06 | 2023-11-14 | The Regents Of The University Of California | Peptide deficient-MHC class I/chaperone compositions and methods |
| EP3817757A4 (en) * | 2018-07-06 | 2022-05-18 | The Regents of the University of California | PEPTIDE-DEFECTIVE MHC CLASS/CHAPERONE COMPOSITIONS AND METHODS |
| CN110950949B (zh) | 2018-09-26 | 2022-04-05 | 香雪生命科学技术（广东）有限公司 | 一种识别ssx2抗原的t细胞受体 |
| US12281338B2 (en) | 2018-10-29 | 2025-04-22 | The Broad Institute, Inc. | Nucleobase editors comprising GeoCas9 and uses thereof |
| US12351837B2 (en) | 2019-01-23 | 2025-07-08 | The Broad Institute, Inc. | Supernegatively charged proteins and uses thereof |
| US12473543B2 (en) | 2019-04-17 | 2025-11-18 | The Broad Institute, Inc. | Adenine base editors with reduced off-target effects |
| CN112409474B (zh) * | 2019-08-23 | 2023-02-28 | 香雪生命科学技术（广东）有限公司 | 一种识别ssx2抗原的高亲和力tcr |
| US12435330B2 (en) | 2019-10-10 | 2025-10-07 | The Broad Institute, Inc. | Methods and compositions for prime editing RNA |
| US11058751B1 (en) | 2020-11-20 | 2021-07-13 | Think Therapeutics, Inc. | Compositions for optimized RAS peptide vaccines |
| CN116710115A (zh) | 2020-11-20 | 2023-09-05 | 思维疗法股份有限公司 | 用于优化的肽疫苗的组合物和方法 |
| US11161892B1 (en) | 2020-12-07 | 2021-11-02 | Think Therapeutics, Inc. | Method of compact peptide vaccines using residue optimization |
| US11421015B2 (en) | 2020-12-07 | 2022-08-23 | Think Therapeutics, Inc. | Method of compact peptide vaccines using residue optimization |
| US11464842B1 (en) | 2021-04-28 | 2022-10-11 | Think Therapeutics, Inc. | Compositions and method for optimized peptide vaccines using residue optimization |
| BR112023022765A2 (pt) | 2021-05-05 | 2024-01-02 | Immatics Biotechnologies Gmbh | Proteínas de ligação ao antígeno que ligam especificamente o prame |
| WO2025050020A1 (en) * | 2023-08-30 | 2025-03-06 | Mink Therapeutics, Inc. | Novel t cell receptors that bind to preferentially expressed antigen in melanoma (prame) and methods of use thereof |
Family Cites Families (60)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US590501A (en) | 1897-09-21 | Xxhixotoh | ||
| US2606601A (en) | 1948-12-14 | 1952-08-12 | Knoll Associates | Chair having a back rest in the form of a shell-like body |
| JP2528457B2 (ja) * | 1987-03-09 | 1996-08-28 | サントリー株式会社 | 過酸化水素の定量法 |
| US6417165B1 (en) | 1988-03-27 | 2002-07-09 | Ludwig Institute For Cancer Research | NY-ESO-1-peptide derivatives, and uses thereof |
| US5804381A (en) * | 1996-10-03 | 1998-09-08 | Cornell Research Foundation | Isolated nucleic acid molecule encoding an esophageal cancer associated antigen, the antigen itself, and uses thereof |
| EP1757694A3 (en) | 1992-11-05 | 2008-02-27 | Sloan Kettering Institute For Cancer Research | Prostate-specific membrane antigen |
| US5747271A (en) | 1992-12-22 | 1998-05-05 | Ludwig Institute For Cancer Research | Method for identifying individuals suffering from a cellular abnormality some of whose abnormal cells present complexes of HLA-A2/tyrosinase derived peptides, and methods for treating said individuals |
| US5620886A (en) | 1993-03-18 | 1997-04-15 | Ludwig Institute For Cancer Research | Isolated nucleic acid sequence coding for a tumor rejection antigen precursor processed to at least one tumor rejection antigen presented by HLA-A2 |
| US5935818A (en) | 1995-02-24 | 1999-08-10 | Sloan-Kettering Institute For Cancer Research | Isolated nucleic acid molecule encoding alternatively spliced prostate-specific membrane antigen and uses thereof |
| US5874560A (en) * | 1994-04-22 | 1999-02-23 | The United States Of America As Represented By The Department Of Health And Human Services | Melanoma antigens and their use in diagnostic and therapeutic methods |
| US5830753A (en) | 1994-09-30 | 1998-11-03 | Ludwig Institute For Cancer Research | Isolated nucleic acid molecules coding for tumor rejection antigen precursor dage and uses thereof. |
| US6025191A (en) | 1995-06-07 | 2000-02-15 | Ludwig Institute For Cancer Research | Isolated nucleic acid molecules which encode a melanoma specific antigen and uses thereof |
| US6548064B1 (en) | 1997-05-05 | 2003-04-15 | Ludwig Institute For Cancer Research | Isolated peptides consisting of amino acid sequences found in SSX or NY-ESO-1 molecules, which bind to HLA molecules |
| US6025470A (en) | 1997-06-23 | 2000-02-15 | Ludwig Institute For Cancer Research | Isolated nona- and decapeptides which bind to HLA molecules, and the use thereof |
| US6994851B1 (en) * | 1997-07-10 | 2006-02-07 | Mannkind Corporation | Method of inducing a CTL response |
| IL133912A0 (en) | 1997-07-10 | 2001-04-30 | Ctl Immunotherapies Corp | A method of inducing ctl response |
| US6977074B2 (en) | 1997-07-10 | 2005-12-20 | Mannkind Corporation | Method of inducing a CTL response |
| US20030138808A1 (en) | 1998-02-19 | 2003-07-24 | Simard John J.L. | Expression vectors encoding epitopes of target-associated antigens |
| US6709844B1 (en) | 2000-11-16 | 2004-03-23 | Mannkind Corporation | Avoidance of undesirable replication intermediates in plasmid propagation |
| US20020072493A1 (en) | 1998-05-19 | 2002-06-13 | Yeda Research And Development Co. Ltd. | Activated T cells, nervous system-specific antigens and their uses |
| IL125608A0 (en) | 1998-07-30 | 1999-03-12 | Yeda Res & Dev | Tumor associated antigen peptides and use of same as anti-tumor vaccines |
| NZ513482A (en) | 1999-02-05 | 2003-08-29 | Univ Melbourne | T helper cell epitodes derived from canine distemper virus for producing an immune response in an animal |
| US6605711B1 (en) | 1999-11-15 | 2003-08-12 | Ludwig Institute For Cancer Research | NY-ESO-1 peptide derivatives, and uses thereof |
| US7462354B2 (en) * | 1999-12-28 | 2008-12-09 | Pharmexa Inc. | Method and system for optimizing minigenes and peptides encoded thereby |
| EP1118860A1 (en) | 2000-01-21 | 2001-07-25 | Rijksuniversiteit te Leiden | Methods for selecting and producing T cell peptide epitopes and vaccines incorporating said selected epitopes |
| WO2001062776A1 (en) | 2000-02-23 | 2001-08-30 | Epimmune Inc. | Hla binding peptides and their uses |
| US6861234B1 (en) | 2000-04-28 | 2005-03-01 | Mannkind Corporation | Method of epitope discovery |
| US20030215425A1 (en) | 2001-12-07 | 2003-11-20 | Simard John J. L. | Epitope synchronization in antigen presenting cells |
| ATE536187T1 (de) * | 2000-10-19 | 2011-12-15 | Epimmune Inc | Hla-klasse-i- und -klasse-ii-bindende peptide und ihre verwendungen |
| BR0100425C2 (pt) | 2001-01-12 | 2003-12-02 | Daniel Villares Lenz Cesar | Filtro autolimpante |
| EP1372736A4 (en) | 2001-03-07 | 2004-11-17 | Mannkind Corp | PREPARATIONS AGAINST CANCER FORMATION |
| JP3830382B2 (ja) | 2001-03-14 | 2006-10-04 | 日本碍子株式会社 | セラミック焼結体およびその製造方法 |
| WO2003008537A2 (en) | 2001-04-06 | 2003-01-30 | Mannkind Corporation | Epitope sequences |
| US20030017134A1 (en) | 2001-06-19 | 2003-01-23 | Technion Research And Development Foundation Ltd. | Methods and pharmaceutical compositions for immune deception, particularly useful in the treatment of cancer |
| CA2394503A1 (en) | 2001-07-23 | 2003-01-23 | Research In Motion Limited | System and method for pushing information to a mobile device |
| CN101024842A (zh) * | 2001-11-07 | 2007-08-29 | 曼康公司 | 编码靶相关抗原表位的表达载体及其设计方法 |
| US8802618B2 (en) | 2002-03-08 | 2014-08-12 | Board Of Regents, The University Of Texas System | Controlled modulation of amino acid side chain length of peptide antigens |
| US20040063120A1 (en) * | 2002-07-10 | 2004-04-01 | The Regents Of The University Of Michigan | Expression profile of lung cancer |
| US20040019571A1 (en) | 2002-07-26 | 2004-01-29 | Intel Corporation | Mobile communication device with electronic token repository and method |
| US20070105779A1 (en) | 2002-07-31 | 2007-05-10 | Danila Valmori | Isolated, ssx-2 and ssx-2 related peptides useful as hla binders and ctl epitopes, and uses thereof |
| EP1542710B1 (en) * | 2002-08-28 | 2012-09-26 | Dyax Corp. | Methods for preserving organs and tissues |
| CN1691964A (zh) | 2002-09-06 | 2005-11-02 | 曼康公司 | 表位序列 |
| MXPA05013973A (es) | 2003-06-17 | 2006-03-02 | Mannkind Corp | Metodos para producir, mejorar y sustentar respuestas inmunes contra epitopes restringidos mhc clase i, para propositos profilacticos o terapeuticos. |
| ATE546153T1 (de) | 2003-06-17 | 2012-03-15 | Mannkind Corp | Kombinationen von tumor-assoziierten antigenen zur behandlung von verschiedenen krebstypen |
| US20060159689A1 (en) | 2004-06-17 | 2006-07-20 | Chih-Sheng Chiang | Combinations of tumor-associated antigens in diagnostics for various types of cancers |
| US20060008468A1 (en) * | 2004-06-17 | 2006-01-12 | Chih-Sheng Chiang | Combinations of tumor-associated antigens in diagnostics for various types of cancers |
| JP2008503494A (ja) | 2004-06-17 | 2008-02-07 | マンカインド コーポレイション | 診断方法を治療方法と統合することによる免疫療法の効力改善 |
| EP2332971B1 (en) * | 2004-06-17 | 2016-02-17 | MannKind Corporation | Epitope analogs |
| US20080206270A1 (en) | 2004-07-08 | 2008-08-28 | Minev Boris R | Enhancing Class I Antigen Presentation With Synthetic Sequences |
| EP2351576A1 (en) | 2004-12-29 | 2011-08-03 | Mannkind Corporation | Methods to trigger, maintain and manipulate immune responses by targeted administration of biological response modifiers into lymphoid organs |
| KR101294290B1 (ko) | 2004-12-29 | 2013-08-07 | 맨카인드 코포레이션 | 예방 또는 치료를 위해 제ｉ류 주조직 적합성복합체〔ｍｈｃ〕-제한 에피토프에 대한 면역 반응을 유발,향상 및 지속하는 방법 |
| EP1838342A2 (en) * | 2004-12-29 | 2007-10-03 | Mannkind Corporation | Methods to bypass cd+4 cells in the induction of an immune response |
| AU2005321898B2 (en) | 2004-12-29 | 2012-07-19 | Mannkind Corporation | Use of compositions comprising various tumor-associated antigens as anti-cancer vaccines |
| US7511119B2 (en) * | 2005-06-17 | 2009-03-31 | Mannkind Corporation | PRAME peptide analogues |
| KR20080033271A (ko) * | 2005-06-17 | 2008-04-16 | 맨카인드 코포레이션 | 암종을 위한 다가 동반이행 및 증폭형 면역치료제 |
| CA2612516C (en) | 2005-06-17 | 2015-03-24 | Mannkind Corporation | Methods and compositions to elicit multivalent immune responses against dominant and subdominant epitopes, expressed on cancer cells and tumor stroma |
| KR101718768B1 (ko) | 2009-12-21 | 2017-03-22 | 삼성전자주식회사 | 휴대용 단말기에서 전력 소모를 줄이기 위한 장치 및 방법 |
| US9469902B2 (en) | 2014-02-18 | 2016-10-18 | Lam Research Corporation | Electroless deposition of continuous platinum layer |
| US9814289B2 (en) | 2015-04-08 | 2017-11-14 | Otter Products, Llc | Protective folio case for an electronic device |
| EP3636238B1 (en) | 2018-10-12 | 2021-04-28 | Liko Research & Development AB | Gates with transition ramps for overhead lifting rails |
-
2006
- 2006-06-16 US US11/455,278 patent/US7511119B2/en not_active Expired - Fee Related
- 2006-06-16 CA CA002612494A patent/CA2612494A1/en not_active Abandoned
- 2006-06-16 US US11/454,633 patent/US7511118B2/en not_active Expired - Fee Related
- 2006-06-16 NZ NZ564359A patent/NZ564359A/en not_active IP Right Cessation
- 2006-06-16 KR KR1020087001200A patent/KR20080028938A/ko not_active Ceased
- 2006-06-16 NZ NZ590125A patent/NZ590125A/en not_active IP Right Cessation
- 2006-06-16 WO PCT/US2006/023489 patent/WO2006138562A2/en not_active Ceased
- 2006-06-16 AU AU2006259307A patent/AU2006259307B2/en not_active Ceased
- 2006-06-16 US US11/454,300 patent/US7605227B2/en not_active Expired - Fee Related
- 2006-06-16 EP EP11155692A patent/EP2371852A3/en not_active Withdrawn
- 2006-06-16 EP EP11155676A patent/EP2371851A3/en not_active Withdrawn
- 2006-06-16 EP EP06784999.2A patent/EP1896498B1/en not_active Not-in-force
- 2006-06-16 CN CNA2006800300090A patent/CN101273056A/zh active Pending
- 2006-06-16 MX MX2007015951A patent/MX2007015951A/es active IP Right Grant
- 2006-06-16 BR BRPI0611793-7A patent/BRPI0611793A2/pt not_active IP Right Cessation
- 2006-06-16 EP EP11155668A patent/EP2371850A3/en not_active Withdrawn
- 2006-06-16 JP JP2008517145A patent/JP2008543314A/ja active Pending
-
2007
- 2007-12-13 IL IL188108A patent/IL188108A/en not_active IP Right Cessation
-
2009
- 2009-03-17 US US12/406,022 patent/US20100303842A1/en not_active Abandoned
-
2010
- 2010-12-13 IL IL209963A patent/IL209963A0/en unknown
-
2012
- 2012-05-25 US US13/481,741 patent/US8653237B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008543314A5 (enExample) | ||
| JP2008510453A5 (enExample) | ||
| JP2002510494A5 (enExample) | ||
| JP2006187292A5 (enExample) | ||
| JP2008529558A5 (enExample) | ||
| JP2006149406A5 (enExample) | ||
| JP2019528693A5 (enExample) | ||
| WO2011039508A3 (en) | T-cell receptor | |
| JP2007513634A5 (enExample) | ||
| CA2248667A1 (en) | Hla-a2.1 binding peptides and their uses | |
| JPWO2021219897A5 (enExample) | ||
| JP2010532656A5 (enExample) | ||
| CA2636075A1 (en) | Chimaeric fusion protein with superior chaperone and folding activities | |
| JP2011522777A5 (enExample) | ||
| JPWO2020027010A5 (enExample) | ||
| JP2008545393A5 (enExample) | ||
| TW201008576A (en) | New fusion proteins and their use for the preparation of vaccines against hepatitis C | |
| WO2003090667A3 (fr) | Composition immunogene ou vaccinale non immunosuppressive, comprenant une proteine e7 mutee du virus hpv-16 | |
| AU5776799A (en) | Modified hcv peptide vaccines | |
| ATE435660T1 (de) | Immunogenes polypeptid bestehend aus optimierten kryptischen peptiden aus tumorantigenen und seine verwendungen | |
| CA2939971A1 (en) | Vaccines based on hepatitis b core antigens | |
| CN110746496B (zh) | 一种鲍曼不动杆菌的pal重组蛋白及其编码基因和它们的应用 | |
| JP2007511534A5 (enExample) | ||
| JP2012501351A5 (enExample) | ||
| NZ603379A (en) | Ect2 peptides and vaccines including the same |